... phẩm bao gói sẵn, thực phẩm đóng hộp phải thiết kế chỗ để nước sát trùng dùng ngâm ủng trước vào 11 Prepare by Bui Viet Trung Cửa sổ: • Phải dễ lau chùi, thiết kế cho hạn chế bám bụi tới mức thấp ... chắn an tồn để tránh bị vỡ bảo đảm trường hợp vỡ, mảnh vỡ khơng rơi vào thực phẩm 14 Prepare by Bui Viet Trung 10 .Dụng cụ chứa chất thải vật phẩm khơng ăn được: a) Phải làm vật liệu bị hư hỏng, ... phân biệt để tránh nhầm lẫn dùng, cần khố để tránh nhiễm bẩn thực phẩm cố ý hay vơ ý 15 Prepare by Bui Viet Trung 16 IV Hệ thống cung cấp nƣớc Prepare by Bui Viet Trung Hệ thống cung cấp nước phải:...
... J-G et al [10 ], Whitehead [11 ] Testicular Cancer Pera MF [12 ] Skin cancer Parkinson EK et al [13 ], Halaban R [14 ] Lung cancer Twentyman PR [15 ], WU R [16 ] Brain cancer Darling JL [17 ] Ovarian ... Publishers 19 91: 15 1 -16 8 10 Park J-G, Ku J-L, Kim H-S, Park S-Y,Rutten MJ Culture of normal and malignant gastric epithelium In: Pfragner R, http://www.medsci.org Int J Med Sci 2 011 , Freshney ... Press; 2006: 10 5 -12 2 70 Dunphy MPS, Lewis JS: Radiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PET J Nucl Med 2009; 50: 10 6S -12 1S 253 71 Institute of Medicine...
... and Drug Administration Good Laboratory Practices Good Storage Practices Good Distribution Practices Good Pharmacy Practices Good Prescribing Practices Good Clinical Practices Standard Operating ... Laboratory Practices GSP Good Storage Practices GDP Good Distribution Practices GPP Good Pharmacy Practices Quality Assurance of Clinical Therapy GCP Good Clinical Practices GPP Good Prescribing Practices ... manufacturers’ revenues in 19 99 are summarized in the graph hereunder Firms' Revenues in 19 99 12 .00 10 .00 Mil U.S $ 8.00 6.00 4.00 2.00 27 25 23 21 19 17 15 13 11 0.00 Firms Figure 3 .1: Local pharmaceutical...
... considered to be an essential marker of Fig Schematic of mechanism of action of the telomeric quadruplex ligand BRACO -19 11 20 FEBS Journal 277 (2 010 ) 11 18 11 25 ª 2009 The Author Journal compilation ... 277 (2 010 ) 11 18 11 25 ª 2009 The Author Journal compilation ª 2009 FEBS 11 19 G-quadruplexes as cancer drug targets S Neidle length of kb, a 24 h cell-doubling time and a subsequent loss of 10 0 ... model BRACO -19 AS1 410 RHPS4 A4 31 epidermal carcinoma A549 lung carcinoma UXF 113 8L human uterine carcinoma HCT 116 , HT29 colorectal carcinomas RHPS4a a Initial tumour size 10 80 mm3 10 mm3 · mm...
... routes Nanotechnology, 18 (2007) - 16 Page 16 of 27 [20] E.H Hall, On a new action of the magnet on electrical current American Journal of Mathematics, (18 79) 287-292 [ 21] R.S Popovic, Hall-effect ... model of SnO2 thin films based on conductance and Hall effect measurements Journal of Applied Physics, 10 0 (2006) 033 716 17 Page 17 of 27 [32] A Oprea, N Ba?rsan, U Weimar, Characterization of granular ... Weimar, Conduction model of metal oxide gas sensors Journal of us [36] cr Semiconductors Reports on Progress in Physics, 43 (19 80) 12 63 -13 07 Electroceramics, (20 01) 14 3 -16 7 N Barsan,U Weimar, Understanding...
... Curr Opin Biotechnol 12 , 638 (20 01) 11 5 F W Studier, Virology 95, 70 (19 79) 11 6 J Yin, J Bacteriol 17 5, 12 72 (19 93) 11 7 D Kong and J Yin, Biotechnology (NY) 13 , 583 (19 95) 11 8 M T Klem, D Willits, ... (20 01) 18 6 T Hogg, Nanotechnology 10 , 300 (19 99) 18 7 N C Seeman, Trends Biotechnol 17 , 437 (19 99) 18 8 J Chen and N C Seeman, Nature 350, 6 31 (19 91) 18 9 Y Zhang and N C Seeman, J Am Chem Soc 11 6, ... 11 6, 16 61 (19 94) 19 0 N C Seeman, Nanotechnology 9, 257 (19 98) 19 1 C Mao, W Sun, Z Shen, and N C Seeman, Nature 397, 14 4 (19 99) 19 2 H Yan, X Zhang, Z Shen and N C Seeman, Nature 415 , 62 (2002) 19 3...
... Delta The names of the producers are withheld for ethical reasons (na- not available) Feed No 01 02 03 04 05 06 07 08 09 10 11 12 Maximum Moisture (%) 11 11 11 11 11 11 11 11 11 10 11 11 Minimum Protein ... na na 636 farms (30) 4300 83 Cao Lanh Chau Thanh 31 (3) 15 1 (8) 12 Hong Ngu Lap Vo 61 (1) 48 (4) 51 20 51 Tan Hong Thanh Binh 38 (1) 77 (13 ) 60 13 346 farms (20) 94 04 Binh Tan Long Ho 38 (6) 53 ... Fingerlings Range 10 -3,500 1- 11 1-30 Mean 38 ,19 3 4.7 8.2 Common problems in the larval stage include deformity (18 %), over-use of hormones (16 %) and high mortality (4.4%) Transport (Q62-66) 16 % of farms...
... of drugs, including its safety profile and its ability to synergize with other conventional or biological immunosuppressive agents 10 11 12 13 14 15 16 17 18 19 Competing interests None declared ... autoimmune manifestations J Exp Med 19 99, 19 0 :16 97 -17 10 Cancro MP: Peripheral B-cell maturation: the intersection of selection and homeostasis Immunol Rev 2004, 19 7:89 -10 1 Avery DT, Kalled SL, Ellyard ... Scott ML: An essential role for BAFF in the normal development of B cells through a BCMAindependent pathway Science 20 01, 293: 211 1- 211 4 Gross JA, Dillon SR, Mudri S, Johnston J, Littau A, Roque...
... Retrovirology 2008, 5:26 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 Lecossier D, Bouchonnet F, Clavel F, Hance AJ: Hypermutation of HIV -1 DNA in the absence of the Vif protein ... Med 2000, 6 (12 ) :13 75 -13 79 Lau JY, Tam RC, Liang TJ, Hong Z: Mechanism of action of ribavirin in the combination treatment of chronic HCV infection Hepatology 2002, 35(5) :10 02 -10 09 Page of (page ... generation time Science 19 96, 2 71: 1582 -15 86 Bourinbaiar AS: The ratio of defective HIV -1 particles to replication-competent infectious virions Acta Virol 19 94, 38 (1) :59- 61 Li Y, Hui H, Burgess...
... [Epub ahead of print] doi :10 .11 86/cc9073 Cite this article as: Barilan YM: The dilemma ofgood clinical practice in the study of compromised standards of care Critical Care 2 010 , 14 :17 6 ... out of intensive care units: a comparative, prospective study of 6 41 ventilations Crit Care 2 010 , 14 :R48 Hubbard RE, Lyons RA, Woodhouse KW, Hillier SL, Warham K, Ferguson B, Major E: Absence of ... has no competing interests Published: 15 July 2 010 References ICH Topic E (R1) Guideline for Good Clinical Practice [http://www.ema europa.eu/pdfs/human/ich/ 013 595en.pdf ] Lieberman D, Nachshon...